Showing results (2121-2130 of 3,060) with videos related to
Sort By:
Pageof 306
Acta Virologica|October 6, 2015
Effect of ORF119 gene deletion on the replication and virulence of orf virusJ Qiao, H B Yang, Y L Peng, et al.Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|December 15, 2018
[The surgical management of upper parapharyngeal regions]X M Wang, H Li, D S Chen, et al.Cancer Research|November 1, 1994
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosisM F Press, M C Pike, G Hung, et al.Journal of Proteome Research|December 2, 2006
Pharmacoproteomics study of cetuximab in nasopharyngeal carcinomaFion L Sung, Ronald T K Pang, Brigette B Y Ma, et al.International Journal of Obstetric Anesthesia|July 29, 2018
Anesthetic management for cesarean delivery in a patient with uncorrected pulmonary atresia, ventricular septal defect and major aortopulmonary collateral arteriesS P Gang, K Y Fang, Y Ma, et al.European Review for Medical and Pharmacological Sciences|July 6, 2017
Downregulated long non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small cell lung cancer cells via activation of p53- p66shc pathwayL-Y Ma, X-W Xie, L Ma, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 26, 2009
IL-1RI deficiency ameliorates early experimental renal interstitial fibrosisLynelle K Jones, Kim M O'Sullivan, Timothy Semple, et al.Transplantation Proceedings|June 24, 2009
Diabetes mellitus after living donor liver transplantation: data from mainland ChinaJ Zhao, L Yan, B Li, et al.European Journal of Clinical Nutrition|September 3, 2015
Comparison of control fasting plasma glucose of exercise-only versus exercise-diet among a pre-diabetic population: a meta-analysisL Zheng, J Wu, G Wang, et al.Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|November 1, 2022
[Comparison of the efficacy and safety of 2 low-dose rituximab regimens in the second-line treatment of primary immune thrombocytopenia in children]X J Zhu, J Y Ma, Z P Chen, et al.Pageof 306